Terms: = Brain cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Prognosis
5 results:
1. Real-World Clinical Outcomes for Patients with
Li K; Bosdet I; Yip S; Ho C; Laskin J; Melosky B; Wang Y; Sun S
Curr Oncol; 2023 Jul; 30(8):7099-7111. PubMed ID: 37622996
[TBL] [Abstract] [Full Text] [Related]
2. Integrative analysis of genomic alteration, immune cells infiltration and prognosis of lung squamous cell carcinoma (LUSC) to identify smoking-related biomarkers.
Li J; Li H; Zhang C; Zhang C; Wang H
Int Immunopharmacol; 2020 Dec; 89(Pt A):107053. PubMed ID: 33045568
[TBL] [Abstract] [Full Text] [Related]
3. A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (zfhx3) by immunohistochemistry suggests malignant progression.
Kawaguchi M; Hara N; Bilim V; Koike H; Suzuki M; Kim TS; Gao N; Dong Y; Zhang S; Fujinawa Y; Yamamoto O; Ito H; Tomita Y; Naruse Y; Sakamaki A; Ishii Y; Tsuneyama K; Inoue M; Itoh J; Yasuda M; Sakata N; Jung CG; Kanazawa S; Akatsu H; Minato H; Nojima T; Asai K; Miura Y
BMC Cancer; 2016 Oct; 16(1):805. PubMed ID: 27756245
[TBL] [Abstract] [Full Text] [Related]
4. Multi-platform, multi-site, microarray-based human tumor classification.
Bloom G; Yang IV; Boulware D; Kwong KY; Coppola D; Eschrich S; Quackenbush J; Yeatman TJ
Am J Pathol; 2004 Jan; 164(1):9-16. PubMed ID: 14695313
[TBL] [Abstract] [Full Text] [Related]
5. [Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis].
Frick S; Lischner S; Rosien F; Haacke TC; Schäfer F; Christophers E; Hauschild A
Hautarzt; 2002 Oct; 53(10):659-65. PubMed ID: 12297947
[TBL] [Abstract] [Full Text] [Related]
